Navigation Links
EMBASE Classic makes inroads into pharmaceutical industry
Date:11/6/2007

Amsterdam, November 6, 2007 Elsevier announced today that major global healthcare company, Bayer HealthCare AG, headquartered in Leverkusen, Germany, has signed an agreement to purchase EMBASE Classic. Available in electronic format for the first time, EMBASE Classic is a fully digitized bibliographic database drawn from 43 Excerpta Medica Abstract Journals published between 1947 and 1973. Covering approximately 3,400 international journals, EMBASE Classic indexes more than 1.8 million records from the biomedical and pharmacological literature.

For Bayer HealthCare and other healthcare and biopharmaceutical companies already licensing EMBASE (covering the literature published from 1974-present) or accessing the file via one of the online vendors, EMBASE Classic allows effective and efficient searching of a single file, from 1947 until today. An important benefit of the addition of EMBASE Classic to EMBASE is the documentation of toxicities and adverse effects that have been published about drugs or endogenous compounds at the time. These drugs may be revisited today or serve as controls because of their known adverse effects or specific effects in animals. In addition results of clinical trials published prior to 1974 can now be more easily factored into evidence-based medical assessments.

Edith Bomers, Project Manager, EMBASE Classic, commented that, We are extremely pleased that the value of EMBASE Classic has already been recognized by Bayer HealthCare AG, one of the worlds leading healthcare companies. EMBASE Classic makes critical biomedical research from the 1950s and 1960s searchable and easily accessible, facilitating much more effective literature searches. In essence it allows revisiting the past to explore the future.

EMBASE Classic contains historic index terms and has been enhanced with additional indexing controlled by the current version of EMTREE to allow for precision retrieval. EMTREE has furthermore been enhanced with historic index terms. For example, the pre-penicillin era drugs oxophenarsine (tradename mapharsen) to treat syphilis and thiazosulfone (tradename promizole) to treat leprosy and tuberculosis have become EMTREE terms.

EMBASE Classic may be acquired directly from Elsevier or from vendors Ovid, Dialog or DataStar. To celebrate the release of EMBASE Classic, an introductory sales offer is currently available.


'/>"/>

Contact: Magdaleine Margaritis
m.margaritis@elsevier.com
31-204-853-091
Elsevier
Source:Eurekalert

Related medicine news :

1. EMBASE Classic Makes Inroads into Pharmaceutical Industry
2. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
3. New Smart Technology Makes Patient Data Collection Easier, More Efficient
4. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
5. Independence Blue Cross Makes Music for Members Ears
6. A Place for Mom COO Makes Seattles 40 Under 40 List
7. Sesame Street Exhibition Makes Texas Premier at The Health Museum
8. Study makes progress in zoning in on biomarkers for better colon cancer treatment
9. New Online Tool Makes Enrollment in Blue Cross of California Easier
10. 1-800-PACK-RAT Makes a Splash During Annual Walk for Hope
11. Eye on Safety Makes Halloween Less Scary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: